Open Access Open Access  Restricted Access Subscription Access

Nanoparticle Based Drug Delivery System: Advantages and Applications


Affiliations
1 Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, India
 

There has been a considerable research interest in the area of drug delivery systems using nanoparticles. Nanostructured biomaterials have unique physicochemical properties such as ultra small and controllable size, large surface area to mass ratio, high reactivity and functionalizable structure. It alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug molecules that are capable of targeted delivery of both imaging agents and anticancer drugs and early detection of cancer lesions, determination of molecular signatures of the tumor by noninvasive imaging and, most importantly, molecular targeted cancer therapy. These properties can be applied on drug to overcoming some of the limitations in traditional therapeutics. They have been used in vivo to protect the drug entity in the systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a controlled and sustained rate to the site of action, minimizes undesirable side effects of the drugs and allow for more efficient use of the drug. It should be present at appropriate concentrations at the target site, and it should not lose its activity or therapeutic efficacy while in circulation. Here, we review various aspects of nanoparticle formulation, characterization, effect of their characteristics and their applications in delivery of drug molecules, improving the targated delivery of therapeutic agents, the potential of nanomedicine, development of novel and more effective diagnostic and screening techniques to extend the limits of molecular diagnostics and challenges in synthesizing nanoparticle platforms for delivering various drugs.

Keywords

Drug Delivery, Microbes, Liposomes, Polymeric Nanoparticles, Ceramic Nanoparticles, Dendrimers
User

  • Ahmad Z, Pandey R, Sharma S and Khuller GK (2006) Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Ind. J. Chest Dis. Allied. Sci. 48, 171-176.
  • Balogh L, Swanson DR, Tomalia DA, Hagnauer GL and McManus AT (2001) Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano.Lett. 1, 18-21
  • Bawa R, Bawa SR and Meibius SB et al. (2005) Protecting new ideas and invention in nanomedicine via patent. Nanomedicine. 1(2), 150-158.
  • Davis ME, Chen ZG and Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature. 7, 771-782.
  • Devarakonda B, Hill RA, Liebenberg W, Brits M and de Villiers MM (2005) Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int. J. pharm. 304(1-2), 193-209.
  • Hughes GA (2005) Nanostructure-mediated drug delivery. Nanomedicine. 1, 22– 30.
  • Jain N, Jain R, Thakur N, Gupta BP, Jain DK, Banveeri J and Jain S (2010) Nanotechnology: a safe and effective drug delivery system. Asian J. Pharm. Clin. Res. 3, Issue 3.
  • Omri A, Suntres ZE and Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem. Pharmacol. 64, 1407-1413.
  • Pandey R and Khuller GK (2006) Oral nanoparticlebased antituberculosis drug delivery to the brain in an experimental model. J. Antimicrob. Chemotherapy. 57(6), 1146-1152.
  • Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R and Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760.
  • Pragati S, Ashok S and Kuldeep S (2009) Recent advances in periodontal drug delivery systems. Int. J. D. Del. 1, 1-14.
  • Rao DP, Srivastav SK, Prasad C, Saxena R and Asthana S (2010) Role of nanoparticles in drug delivery. Int. J. Nanotech. App. 0973-631X Volume 4.
  • Schumacher I and Margalit R (1997) Liposomeencapsulated ampicillin: physicochemical and antibacterial properties. J. Pham. Sci. 86, 635-641.
  • Wadher K, Kalsait R and Umekar M (2009) Alternate drug delivery system: recent advancement and future challenges. Arch. Pharm. Sci. Res. 1 No. 2, 97 - 105.
  • Yih TC and Al-Fandi M (2006) Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 97, 1184–1190.
  • Zhang L, Gu FX, Chan JM, Wang AZ, Langer R.S and Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83(5), 761-769.
  • Zhang L, Pornpattananangkul D, Hu CMJ and Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem.17, 585-594.

Abstract Views: 668

PDF Views: 130




  • Nanoparticle Based Drug Delivery System: Advantages and Applications

Abstract Views: 668  |  PDF Views: 130

Authors

Sandeep Singh
Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, India
Vivek Kumar Pandey
Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, India
Ravi Prakash Tewari
Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, India
Vishnu Agarwal
Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, India

Abstract


There has been a considerable research interest in the area of drug delivery systems using nanoparticles. Nanostructured biomaterials have unique physicochemical properties such as ultra small and controllable size, large surface area to mass ratio, high reactivity and functionalizable structure. It alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug molecules that are capable of targeted delivery of both imaging agents and anticancer drugs and early detection of cancer lesions, determination of molecular signatures of the tumor by noninvasive imaging and, most importantly, molecular targeted cancer therapy. These properties can be applied on drug to overcoming some of the limitations in traditional therapeutics. They have been used in vivo to protect the drug entity in the systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a controlled and sustained rate to the site of action, minimizes undesirable side effects of the drugs and allow for more efficient use of the drug. It should be present at appropriate concentrations at the target site, and it should not lose its activity or therapeutic efficacy while in circulation. Here, we review various aspects of nanoparticle formulation, characterization, effect of their characteristics and their applications in delivery of drug molecules, improving the targated delivery of therapeutic agents, the potential of nanomedicine, development of novel and more effective diagnostic and screening techniques to extend the limits of molecular diagnostics and challenges in synthesizing nanoparticle platforms for delivering various drugs.

Keywords


Drug Delivery, Microbes, Liposomes, Polymeric Nanoparticles, Ceramic Nanoparticles, Dendrimers

References





DOI: https://doi.org/10.17485/ijst%2F2011%2Fv4i3%2F29960